Skip to content

Comparison between Ahmed Glaucoma Valve Implantation in eyes with refractory glaucoma with and without Phacoemulsification

Comparison between Ahmed Glaucoma Valve Implantation in eyes with refractory glaucoma with and without Phacoemulsification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074639
Enrollment
Unknown
Registered
2023-08-11
Start date
2023-08-15
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary open angle glaucoma

Interventions

AGVI group (Patients who only implement AGVI):No
Phaco-AGVI group:No

Sponsors

Hangzhou Branch of Eye and Optometry Hospital Affiliated to Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? at least 18 years of age; ? failed POAG treatment to achieve the target IOP even under maximum medications and several antiglaucoma surgeries; ?intolerance to topical medications or high risk of trabeculectomy failure; ?follow-up visits for 2 years postoperatively.

Exclusion criteria

Exclusion criteria: ? patients with previously implanted artificial intraocular lenses (IOLs); ? patients without lenses; ? patients complicated with other ocular disorders, including corneal opacity, lens dislocation, ischemic optic neuropathy and diabetic retinopathy; ? patients who underwent additional surgeries (e.g., phacoemulsification) at the 2-year follow-up.

Design outcomes

Primary

MeasureTime frame
Cumulative probability of success;

Secondary

MeasureTime frame
Intraocular pressure;Visual acuity;Axial length;Visual field index;Mean deviation;Pattern standard deviation of the Humphrey visual field;Lens status;The number of topical glaucoma medications;

Countries

China

Contacts

Public ContactFu Lin

Hangzhou Branch of Eye and Optometry Hospital Affiliated to Wenzhou Medical University

fulinzd@163.com+86 183 5711 5864

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026